Lassar’s Cream.Zinc Oxide 23% w/w & Salicylic Acid 2% w/w Ireland - English - HPRA (Health Products Regulatory Authority)

lassar’s cream.zinc oxide 23% w/w & salicylic acid 2% w/w

ovelle limited - zinc oxide; salicylic acid - cream - 23% w/w & 2 percent weight/weight - salicylic acid preparations

TUBERCULIN PPD RT 23 AJV Singapore - English - HSA (Health Sciences Authority)

tuberculin ppd rt 23 ajv

dksh singapore pte. ltd. - tuberculin ppd rt 23 - injection - 0.4mcg - tuberculin ppd rt 23 0.4 mcg/ml

Metoprolol Succinate Extended Release Tablets New Zealand - English - Medsafe (Medicines Safety Authority)

metoprolol succinate extended release tablets

aft pharmaceuticals ltd - metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg - modified release tablet - 23.75 mg - active: metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg excipient: cellulose acetate crospovidone glyceryl monostearate hypromellose methacrylic acid copolymer microcrystalline cellulose opadry clear ys-1-7006 opadry white ys-1-7003 poloxamer 188 polysorbate 80 sugar spheres - metoprolol succinate extended-release tablets are indicated for the treatment of: hypertension - to lower blood pressure. lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.

Minax XL New Zealand - English - Medsafe (Medicines Safety Authority)

minax xl

viatris limited - metoprolol succinate 23.75mg - modified release tablet - 23.75 mg - active: metoprolol succinate 23.75mg excipient: colloidal silicon dioxide ethylcellulose hypromellose macrogol 400 macrogol 6000 microcrystalline cellulose opadry white 32k58900 purified water sodium stearyl fumarate - · hypertension. to reduce blood pressure and to reduce the risk of cardiovascular and coronary mortality (including sudden death), and morbidity. · paediatric hypertension.

PNEUMOVAX 23 pneumococcal purified capsular polysaccharides 25 microgram/0.5mL injection pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

pneumovax 23 pneumococcal purified capsular polysaccharides 25 microgram/0.5ml injection pre-filled syringe

merck sharp & dohme (australia) pty ltd - pneumococcal purified capsular polysaccharides, quantity: 50 microgram/ml - injection, solution - excipient ingredients: water for injections; phenol; sodium chloride - pneumovax 23 is indicated for immunisation of individuals in the following situations: all individuals over the age of 65 years; individuals with asplenia, either functional or anatomical, including sickle cell disease, in persons more than 2 years of age; where possible the vaccine should be given at least 14 days before splenectomy; immunocompromised patients at increased risk of pneumococcal disease (eg patients with hiv infection before the development of aids, nephrotic syndrome, multiple myeloma, lymphoma, hodgkin's disease and organ transplantation); aboriginal and torres strait islander people over 50 years of age; immunocompetent persons at increased risk of complications from pneumococcal disease because of chronic illness (eg chronic cardiac, renal or pulmonary disease, diabetes mellitus, alcoholism and cirrhosis); patients with cerebrospinal fluid leaks. in australia, the national health and medical research council (nhmrc) currently recommends the vaccination of tobacco smokers with the 23-valent polysaccharide pneumococcal vaccine. pneumovax 23 is indicated for immunisation only against pneumococcal disease caused by those pneumococcal types included in the vaccine. effectiveness of the vaccine in the prevention of pneumococcal pneumonia and pneumococcal bacteremia has been demonstrated. in australia, the national health and medical research council (nhmrc) currently recommeds the vaccination of tabacco smokers with the 23-valent polysaccharide pneumococcal vaccine. pneumovax 23 will not prevent disease caused by capsular types of pneumococcus othar those contained in the vaccine.

CALCIUM GLUCONATE INJ 23% LIQUID Canada - English - Health Canada

calcium gluconate inj 23% liquid

central sales limited - calcium borogluconate - liquid - 23% - calcium borogluconate 23% - cats; cattle; dogs; horses; sheep; swine (pigs)

SODIUM CHLORIDE ADDITIVE SOLN 23.4% LIQUID Canada - English - Health Canada

sodium chloride additive soln 23.4% liquid

international medication systems ltd. - sodium chloride - liquid - 23.4g - sodium chloride 23.4g - replacement preparations

CALCIUM GLUCONATE 23% INJ SOLUTION Canada - English - Health Canada

calcium gluconate 23% inj solution

univet pharmaceuticals ltd. - calcium borogluconate - solution - 23% - calcium borogluconate 23% - cattle; horses; sheep; swine (pigs)

LADY SPEED STICK ANTIPERSPIRANT 23% Canada - English - Health Canada

lady speed stick antiperspirant 23%

mennen canada inc. - aluminum zirconium tetrachlorohydrex gly - stick - 23% - aluminum zirconium tetrachlorohydrex gly 23% - astringents and deodorants

CALCIUM BOROGLUCONATE 23% LIQ SOLUTION Canada - English - Health Canada

calcium borogluconate 23% liq solution

citadel animal health - calcium borogluconate - solution - 23% - calcium borogluconate 23% - cattle; sheep; swine (pigs)